MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Let’s Talk Medtech

Will 2022 Be Medtech's Biggest Year for M&A?

Image Courtesy of EY John Babitt EY.jpg
Will 2022 be the year of medtech M&A. EY’s John Babitt joins us to talk about acquisition trends and deal-making activity in the latest episode of Let’s Talk Medtech.

Medtech M&A took off in 2021 and if there’s any indication to the recent earnings reports that came out, 2022 could be an even bigger year.  John Babitt, a Life Science Partner with EY joins us for this episode of Let’s Talk Medtech for a candid conversation regarding M&A.

Babitt speaks on trends reported in EY’s Annual M&A Firepower Report. Click here for a transcript of the first 1,000 words of Let’s Talk Medtech’s conversation with John Babitt, and check below for the full episode.



TAGS: Podcasts
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.